ObsEva announces Brian O’Callaghan as CEO

– SWITZERLAND, Geneva –  ObsEva SA (NASDAQ: OBSV | SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health today announced the appointment of Brian O’Callaghan as CEO effective 1st December 2020 succeeding Dr.…